Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sjögren's syndrome. (2023)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kead115
PubMed Identifier: 36897029
Publication URI: http://europepmc.org/abstract/MED/36897029
Type: Journal Article/Review
Volume: 62
Parent Publication: Rheumatology (Oxford, England)
Issue: 9
ISSN: 1462-0324